Source: European Journal of Pharmacology. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, APOPTOSE, NEOPLASIAS DE CABEÇA E PESCOÇO, MITOCÔNDRIAS, NEOVASCULARIZAÇÃO PATOLÓGICA
ABNT
GOTO, Renata Nishida et al. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma. European Journal of Pharmacology, v. 819, p. 198-206, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2017.12.009. Acesso em: 07 nov. 2024.APA
Goto, R. N., Sobral, L. M., Sousa, L. O., Garcia, C. B., Lopes, N. P., Marín-Prida, J., et al. (2018). Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma. European Journal of Pharmacology, 819, 198-206. doi:10.1016/j.ejphar.2017.12.009NLM
Goto RN, Sobral LM, Sousa LO, Garcia CB, Lopes NP, Marín-Prida J, Ochoa-Rodríguez E, Verdecia-Reyes Y, Pardo-Andreu GL, Curti C, Leopoldino AM. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma [Internet]. European Journal of Pharmacology. 2018 ; 819 198-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.12.009Vancouver
Goto RN, Sobral LM, Sousa LO, Garcia CB, Lopes NP, Marín-Prida J, Ochoa-Rodríguez E, Verdecia-Reyes Y, Pardo-Andreu GL, Curti C, Leopoldino AM. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma [Internet]. European Journal of Pharmacology. 2018 ; 819 198-206.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejphar.2017.12.009